BiotechTube

ASP2151 + valacyclovir + Placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Herpes Genitalis

Conditions

Herpes Genitalis

Trial Timeline

Jun 21, 2007 → Aug 12, 2008

NCT ID
NCT00486200

About ASP2151 + valacyclovir + Placebo

ASP2151 + valacyclovir + Placebo is a phase 2 stage product being developed by Astellas Pharma for Herpes Genitalis. The current trial status is completed. This product is registered under clinical trial identifier NCT00486200. Target conditions include Herpes Genitalis.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT00870441Phase 1Terminated
NCT00486200Phase 2Completed

Competing Products

20 competing products in Herpes Genitalis

See all competitors
ProductCompanyStageHype Score
ASP2151 + Valacyclovir hydrochlorideAstellas PharmaPhase 2
52
ASP2151 + PlaceboAstellas PharmaPhase 1
33
Dolutegravir 50 mg tablet + Dolutegravir 50 mg oral granulesShionogiPhase 1
33
GSK1349572 + EfavirenzShionogiPhase 1
33
Zoster Vaccine, Live + Comparator: PlaceboMerckPhase 2
52
Comparator: V212 + Comparator: PlaceboMerckPhase 1
33
Zoster Vaccine, LiveMerckPhase 3
77
V212 + PlaceboMerckPhase 3
77
zoster vaccine live (ZOSTAVAX™) + Comparator: PlaceboMerckPhase 3
77
ZOSTAVAXMerckPhase 3
77
Zoster Vaccine, Live (AMP) + Zoster Vaccine, LiveMerckPhase 3
77
V212 + PlaceboMerckPhase 2
52
V212 + Matching placeboMerckPhase 3
77
V212 Lot 1 + V212 Lot 2 + V212 Lot 3MerckPhase 3
77
HSV 2 Formulation 1 + HSV 2 Formulation 2 + HSV 2 Formulation 3 + HSV 2 Formulation 4 + HSV 2 Formulation 5 + HSV 2 Formulation 6 + Sodium Chloride 0.9%MerckPhase 1
33
V212 + PlaceboMerckPhase 1
33
Zoster Vaccine, Live, (Oka-Merck), ZOSTAVAX™ + Comparator: placebo (concomitant-vaccine matched) + Pneumococcal Vaccine, Polyvalent (23-valent), PNEUMOVAX™ 23MerckPhase 3
77
ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Subcutaneous + ZOSTAVAX™ (Zoster Vaccine Live) 1/3 Dose Subcutaneous + ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Intradermal + ZOSTAVAX™ (Zoster Vaccine Live) Partial Doses Intradermal + Full Dose Intradermal Placebo + Intradermal PlaceboMerckPhase 1
33
ZOSTAVAX™ (concomitant) + Comparator: Influenza Vaccine + ZOSTAVAX™ (Nonconcomitant)MerckPhase 3
77
ZOSTAVAX™MerckPre-clinical
23

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85